27 years of historical data (1999–2025) · Healthcare · Medical - Care Facilities
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Cross Country Healthcare, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 10.6x P/FCF, 82% above the 5-year average of 5.8x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $426M | $263M | $606M | $803M | $997M | $1.0B | $320M | $416M | $261M | $461M | $566M |
| Enterprise Value | $319M | $156M | $528M | $791M | $1.2B | $1.2B | $397M | $510M | $329M | $535M | $632M |
| P/E Ratio → | -4.49 | — | — | 11.04 | 5.29 | 7.86 | — | — | — | 12.63 | 104.07 |
| P/S Ratio | 0.40 | 0.25 | 0.45 | 0.40 | 0.36 | 0.62 | 0.38 | 0.51 | 0.32 | 0.53 | 0.68 |
| P/B Ratio | 1.32 | 0.81 | 1.45 | 1.70 | 2.18 | 3.49 | 2.07 | 2.55 | 1.20 | 1.94 | 3.73 |
| P/FCF | 10.62 | 6.55 | 5.44 | 3.42 | 7.96 | — | 14.17 | 159.94 | 15.94 | 11.42 | 23.95 |
| P/OCF | 8.83 | 5.44 | 5.05 | 3.23 | 7.44 | — | 11.77 | 75.09 | 12.45 | 10.14 | 18.77 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Cross Country Healthcare, Inc.'s enterprise value stands at 24.0x EBITDA, 86% below its 5-year average of 172.4x. The Healthcare sector median is 14.2x, placing the stock at a 69% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.15 | 0.39 | 0.39 | 0.41 | 0.74 | 0.47 | 0.62 | 0.40 | 0.62 | 0.76 |
| EV / EBITDA | 23.96 | 11.71 | 832.13 | 6.04 | 4.08 | 8.29 | 964.73 | — | — | 24.41 | 41.14 |
| EV / EBIT | — | — | — | 7.13 | 4.30 | 8.49 | 24.30 | 57.52 | — | 62.84 | 19.67 |
| EV / FCF | — | 3.89 | 4.74 | 3.37 | 9.19 | — | 17.55 | 196.03 | 20.03 | 13.25 | 26.76 |
Margins and return-on-capital ratios measuring operating efficiency
Cross Country Healthcare, Inc. earns an operating margin of -0.3%. Operating margins have compressed from 5.6% to -0.3% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -25.6% indicates the company is currently destroying shareholder equity.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 18.7% | 18.7% | 20.4% | 22.3% | 22.3% | 22.4% | 24.2% | 24.8% | 25.7% | 26.4% | 26.6% |
| Operating Margin | -0.3% | -0.3% | -1.3% | 5.6% | 9.6% | 8.3% | -1.1% | -1.9% | -1.6% | 1.4% | 0.7% |
| Net Profit Margin | -9.0% | -9.0% | -1.1% | 3.6% | 6.6% | 7.9% | -1.5% | -7.0% | -2.1% | 4.3% | 1.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -25.6% | -25.6% | -3.3% | 15.6% | 49.3% | 58.4% | -8.1% | -30.2% | -7.4% | 19.3% | 5.4% |
| ROA | -18.3% | -18.3% | -2.3% | 8.9% | 22.1% | 24.2% | -3.5% | -14.3% | -3.8% | 8.8% | 2.1% |
| ROIC | -0.9% | -0.9% | -3.2% | 15.8% | 36.7% | 28.9% | -2.8% | -4.3% | -3.2% | 3.3% | 2.1% |
| ROCE | -0.8% | -0.8% | -3.4% | 18.7% | 44.6% | 35.0% | -3.3% | -4.9% | -3.6% | 3.5% | 2.2% |
Solvency and debt-coverage ratios — lower is generally safer
Cross Country Healthcare, Inc. carries a Debt/EBITDA ratio of 0.2x, which is very conservative (95% below the sector average of 3.2x). The company holds a net cash position — cash of $109M exceeds total debt of $2M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.35 | 0.66 | 0.50 | 0.58 | 0.38 | 0.42 | 0.57 |
| Debt / EBITDA | 0.17 | 0.17 | 6.10 | 0.04 | 0.56 | 1.31 | 189.79 | — | — | 4.52 | 5.66 |
| Net Debt / Equity | — | -0.33 | -0.19 | -0.02 | 0.34 | 0.65 | 0.49 | 0.57 | 0.31 | 0.31 | 0.44 |
| Net Debt / EBITDA | -7.98 | -7.98 | -122.46 | -0.09 | 0.55 | 1.31 | 185.89 | — | — | 3.36 | 4.32 |
| Debt / FCF | — | -2.65 | -0.70 | -0.05 | 1.23 | — | 3.38 | 36.08 | 4.10 | 1.82 | 2.81 |
| Interest Coverage | -1.56 | -1.56 | -0.33 | 13.71 | 18.59 | 21.13 | 5.65 | 1.67 | -2.22 | 2.02 | 5.26 |
Net cash position: cash ($109M) exceeds total debt ($2M)
Short-term solvency ratios and asset-utilisation metrics
Cross Country Healthcare, Inc.'s current ratio of 3.78x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has improved from 2.79x to 3.78x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.78 | 3.78 | 2.78 | 2.79 | 2.49 | 2.54 | 1.96 | 2.15 | 2.28 | 2.21 | 2.12 |
| Quick Ratio | 3.78 | 3.78 | 2.78 | 2.79 | 2.45 | 2.54 | 1.96 | 2.15 | 2.21 | 2.15 | 2.05 |
| Cash Ratio | 1.40 | 1.40 | 0.68 | 0.12 | 0.01 | 0.01 | 0.02 | 0.01 | 0.19 | 0.27 | 0.21 |
| Asset Turnover | — | 2.35 | 2.28 | 2.97 | 2.96 | 2.29 | 2.34 | 2.15 | 1.91 | 1.85 | 2.15 |
| Inventory Turnover | — | — | — | — | 196.88 | — | — | — | 97.76 | 120.38 | 99.87 |
| Days Sales Outstanding | — | 57.99 | 65.96 | 70.18 | 85.93 | 108.62 | 76.24 | 77.48 | 76.14 | 74.73 | 77.36 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Cross Country Healthcare, Inc. returns 1.6% to shareholders annually primarily through share buybacks.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | 9.1% | 18.9% | 12.7% | — | — | — | 7.9% | 1.0% |
| FCF Yield | 9.4% | 15.3% | 18.4% | 29.2% | 12.6% | — | 7.1% | 0.6% | 6.3% | 8.8% | 4.2% |
| Buyback Yield | 1.6% | 2.6% | 6.2% | 7.2% | 3.5% | 0.2% | 0.2% | 0.2% | 1.9% | 0.4% | 0.0% |
| Total Shareholder Yield | 1.6% | 2.6% | 6.2% | 7.2% | 3.5% | 0.2% | 0.2% | 0.2% | 1.9% | 0.4% | 0.0% |
| Shares Outstanding | — | $32M | $33M | $35M | $38M | $37M | $36M | $36M | $36M | $36M | $36M |
Compare CCRN with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $426M | -4.5 | 24.0 | 10.6 | 18.7% | -0.3% | -25.6% | -0.9% | 0.2 | |
| $1B | -12.5 | 10.4 | 5.1 | 28.3% | 1.2% | -14.2% | 1.6% | 4.2 | |
| $203M | -4.2 | 170.2 | — | 21.2% | -1.7% | -16.3% | -5.2% | 83.1 | |
| $2B | 28.3 | 23.1 | 11.8 | 13.0% | 2.6% | 11.7% | 9.0% | 0.4 | |
| $394M | -1.6 | — | 3.5 | 20.1% | -1.6% | -23.0% | -4.0% | — | |
| $2B | -115.7 | 9.5 | — | 16.7% | 1.3% | -0.6% | 5.6% | 7.4 | |
| $895M | 8.1 | 5.3 | 3.1 | 27.2% | 6.5% | 6.3% | 6.9% | 3.2 | |
| $4B | 15.5 | 7.6 | 12.3 | 88.6% | 12.6% | 13.6% | 18.6% | 1.3 | |
| $8B | 69.5 | 55.1 | 105.3 | 73.8% | 4.5% | 25.2% | 8.6% | 7.9 | |
| $2B | 128.5 | 21.3 | 7.3 | 73.4% | 0.1% | 1.2% | 0.0% | 2.4 | |
| $1B | -7.1 | 17.1 | 5.1 | 69.5% | -10.4% | -13.9% | -11.5% | 10.4 | |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 27 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CCRN stock.
Cross Country Healthcare, Inc.'s current P/E ratio is -4.5x. The historical average is 39.2x.
Cross Country Healthcare, Inc.'s current EV/EBITDA is 24.0x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 15.0x.
Cross Country Healthcare, Inc.'s return on equity (ROE) is -25.6%. The historical average is 1.3%.
Based on historical data, Cross Country Healthcare, Inc. is trading at a P/E of -4.5x. Compare with industry peers and growth rates for a complete picture.
Cross Country Healthcare, Inc. has 18.7% gross margin and -0.3% operating margin.
Cross Country Healthcare, Inc.'s Debt/EBITDA ratio is 0.2x, indicating low leverage. A ratio below 2x is generally considered financially healthy.